Michael Chrobok

682 total citations
11 papers, 436 citations indexed

About

Michael Chrobok is a scholar working on Oncology, Immunology and Molecular Biology. According to data from OpenAlex, Michael Chrobok has authored 11 papers receiving a total of 436 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Oncology, 7 papers in Immunology and 5 papers in Molecular Biology. Recurrent topics in Michael Chrobok's work include CAR-T cell therapy research (7 papers), Immune Cell Function and Interaction (6 papers) and Viral Infectious Diseases and Gene Expression in Insects (2 papers). Michael Chrobok is often cited by papers focused on CAR-T cell therapy research (7 papers), Immune Cell Function and Interaction (6 papers) and Viral Infectious Diseases and Gene Expression in Insects (2 papers). Michael Chrobok collaborates with scholars based in Sweden, United States and Türkiye. Michael Chrobok's co-authors include Evren Alici, Adil Doganay Duru, Carin Dahlberg, Dhifaf Sarhan, Arnika Kathleen Wagner, Hareth Nahi, Daniela Nascimento Silva, Per Ljungman, Johan Lund and Astrid Gruber and has published in prestigious journals such as PLoS ONE, Frontiers in Immunology and European Journal of Immunology.

In The Last Decade

Michael Chrobok

11 papers receiving 428 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michael Chrobok Sweden 9 245 245 120 69 34 11 436
Philippe De La Rochère France 6 206 0.8× 202 0.8× 149 1.2× 76 1.1× 37 1.1× 7 478
Jan Davidson‐Moncada United States 12 228 0.9× 215 0.9× 161 1.3× 89 1.3× 27 0.8× 49 518
Jovian Yu United States 11 232 0.9× 216 0.9× 173 1.4× 43 0.6× 20 0.6× 25 506
Carin Dahlberg Sweden 12 161 0.7× 349 1.4× 103 0.9× 28 0.4× 33 1.0× 16 494
Amélien Sanlaville France 6 409 1.7× 619 2.5× 218 1.8× 44 0.6× 46 1.4× 6 868
Athalia R. Pyzer United States 9 183 0.7× 200 0.8× 156 1.3× 57 0.8× 15 0.4× 23 398
Melinda K. Hexum United States 6 348 1.4× 312 1.3× 222 1.9× 55 0.8× 28 0.8× 8 507
Christian Augsberger Germany 5 282 1.2× 197 0.8× 180 1.5× 133 1.9× 22 0.6× 9 484
Élodie Picarda France 9 348 1.4× 448 1.8× 129 1.1× 27 0.4× 39 1.1× 13 688
Qods Lahmar Belgium 6 318 1.3× 527 2.2× 168 1.4× 38 0.6× 24 0.7× 6 637

Countries citing papers authored by Michael Chrobok

Since Specialization
Citations

This map shows the geographic impact of Michael Chrobok's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Chrobok with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Chrobok more than expected).

Fields of papers citing papers by Michael Chrobok

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Chrobok. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Chrobok. The network helps show where Michael Chrobok may publish in the future.

Co-authorship network of co-authors of Michael Chrobok

This figure shows the co-authorship network connecting the top 25 collaborators of Michael Chrobok. A scholar is included among the top collaborators of Michael Chrobok based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael Chrobok. Michael Chrobok is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Silva, Daniela Nascimento, Michael Chrobok, Giulia Rovesti, et al.. (2022). Process Development for Adoptive Cell Therapy in Academia: A Pipeline for Clinical-Scale Manufacturing of Multiple TCR-T Cell Products. Frontiers in Immunology. 13. 896242–896242. 10 indexed citations
2.
Silva, Daniela Nascimento, Michael Chrobok, Gustaf Ahlén, et al.. (2022). ATMP development and pre-GMP environment in academia: a safety net for early cell and gene therapy development and manufacturing. Immuno-Oncology Technology. 16. 100099–100099. 22 indexed citations
3.
Abomaray, Fawaz, Arnika Kathleen Wagner, Michael Chrobok, et al.. (2021). The Effect of Mesenchymal Stromal Cells Derived From Endometriotic Lesions on Natural Killer Cell Function. Frontiers in Cell and Developmental Biology. 9. 612714–612714. 5 indexed citations
4.
Silva, Daniela Nascimento, Giulia Rovesti, Michael Chrobok, et al.. (2021). Liquid Biopsy in Hepatocellular Carcinoma: Opportunities and Challenges for Immunotherapy. Cancers. 13(17). 4334–4334. 24 indexed citations
5.
Petrus-Reurer, Sandra, Nerges Winblad, Pankaj Kumar, et al.. (2020). Generation of Retinal Pigment Epithelial Cells Derived from Human Embryonic Stem Cells Lacking Human Leukocyte Antigen Class I and II. Stem Cell Reports. 14(4). 648–662. 47 indexed citations
6.
Chrobok, Michael, Didem Özkazanç, Benjamin J. Josey, et al.. (2020). Boosting Natural Killer Cell-Mediated Targeting of Sarcoma Through DNAM-1 and NKG2D. Frontiers in Immunology. 11. 40–40. 47 indexed citations
7.
Chrobok, Michael, Anna‐Maria Georgoudaki, Benjamin J. Josey, et al.. (2020). Abstract A55: Natural killer cells genetically modified to overexpress DNAM-1 exert enhanced antitumor responses against CD112/CD155+ sarcomas and other malignancies. Cancer Immunology Research. 8(4_Supplement). A55–A55. 1 indexed citations
8.
Nahi, Hareth, Michael Chrobok, Johan Lund, et al.. (2019). Infectious complications and NK cell depletion following daratumumab treatment of Multiple Myeloma. PLoS ONE. 14(2). e0211927–e0211927. 75 indexed citations
9.
Özkazanç, Didem, Anna‐Maria Georgoudaki, Benjamin J. Josey, et al.. (2019). Engineering antigen‐specific NK cell lines against the melanoma‐associated antigen tyrosinase via TCR gene transfer. European Journal of Immunology. 49(8). 1278–1290. 37 indexed citations
10.
Chrobok, Michael, Carin Dahlberg, Vladimir Beljanski, et al.. (2019). Functional Assessment for Clinical Use of Serum-Free Adapted NK-92 Cells. Cancers. 11(1). 69–69. 23 indexed citations
11.
Dahlberg, Carin, Dhifaf Sarhan, Michael Chrobok, Adil Doganay Duru, & Evren Alici. (2015). Natural Killer Cell-Based Therapies Targeting Cancer: Possible Strategies to Gain and Sustain Anti-Tumor Activity. Frontiers in Immunology. 6. 145 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Philippe De La Rochère Breakdown of academic impact, for papers by Jan Davidson‐Moncada Breakdown of academic impact, for papers by Jovian Yu Breakdown of academic impact, for papers by Carin Dahlberg Breakdown of academic impact, for papers by Amélien Sanlaville Breakdown of academic impact, for papers by Athalia R. Pyzer Breakdown of academic impact, for papers by Melinda K. Hexum Breakdown of academic impact, for papers by Christian Augsberger Breakdown of academic impact, for papers by Élodie Picarda Breakdown of academic impact, for papers by Qods Lahmar
Rankless by CCL
2026